Abstract:Combinations of biomaterials and cells can effectively target delivery of cells or other therapeutic factors to the brain to rebuild damaged nerve pathways after brain injury. Porous collagen-chitosan scaffolds were prepared by a freeze-drying method based on brain tissue engineering. The scaffolds were impregnated with rat bone marrow mesenchymal stem cells. A traumatic brain injury rat model was established using the 300 g weight free fall impact method. Bone marrow mesenchymal stem cells/collagen-chitosan scaffolds were implanted into the injured brain. Modified neurological severity scores were used to assess the recovery of neurological function. The Morris water maze was employed to determine spatial learning and memory abilities. Hematoxylin-eosin staining was performed to measure pathological changes in brain tissue. Immunohistochemistry was performed for vascular endothelial growth factor and for 5-bromo-2-deoxyuridine (BrdU)/neuron specific enolase and BrdU/glial fibrillary acidic protein. Our results demonstrated that the transplantation of bone marrow mesenchymal stem cells and collagen-chitosan scaffolds to traumatic brain injury rats remarkably reduced modified neurological severity scores, shortened the average latency of the Morris water maze, increased the number of platform crossings, diminished the degeneration of damaged brain tissue, and increased the positive reaction of vascular endothelial growth factor in the transplantation and surrounding areas. At 14 days after transplantation, increased BrdU/glial fibrillary acidic protein expression and decreased BrdU/neuron specific enolase expression were observed in bone marrow mesenchymal stem cells in the injured area. The therapeutic effect of bone marrow mesenchymal stem cells and collagen-chitosan scaffolds was superior to stereotactic injection of bone marrow mesenchymal stem cells alone. To test the biocompatibility and immunogenicity of bone marrow mesenchymal stem cells and collagen-chitosan scaffolds, immunosuppressive cyclosporine was intravenously injected 12 hours before transplantation and 1-5 days after transplantation. The above indicators were similar to those of rats treated with bone marrow mesenchymal stem cells and collagen-chitosan scaffolds only. These findings indicate that transplantation of bone marrow mesenchymal stem cells in a collagen-chitosan scaffold can promote the recovery of neuropathological injury in rats with traumatic brain injury. This approach has the potential to be developed as a treatment for traumatic brain injury in humans. All experimental procedures were approved by the Institutional Animal Investigation Committee of Capital Medical University, China (approval No. AEEI-2015-035) in December 2015.

In Vitro Assessment of Biodegradable and Biocompatible Brain-Derived Neurotrophic Factor-Mesenchymal Stem Cells Incorporated Chitosan/Gelatin Scaffold

From Common Biomass Materials to High-Performance Tissue Engineering Scaffold: Biomimetic Preparation, Properties Characterization, in Vitro and in Vivo Evaluations

Experimental Study on Cultivation and Purification of Bone Marrow-Derived Mesenchymal Stem Cells and Its Co-Culture with Chitosan Porous Scaffolds in Vitro

Silk Fibroin/chitosan Scaffold with Tunable Properties and Low Inflammatory Response Assists the Differentiation of Bone Marrow Mesenchymal Stem Cells.

Differentiation of Rat Bone Marrow Mesenchymal Stem Cells Into Neuron-Like Cells In Vitro and Co-Cultured with Biological Scaffold as Transplantation Carrier.

Collagen-chitosan Scaffold Impregnated with Bone Marrow Mesenchymal Stem Cells for Treatment of Traumatic Brain Injury.

In vitro proliferation of mesenchymal stem cells on three-dimensional macroporous scaffolds of chitosan-gelatin-basic fibroblast growth factor composite

A Nanostructured Molybdenum Disulfide Film for Promoting Neural Stem Cell Neuronal Differentiation: Toward a Nerve Tissue‐Engineered 3D Scaffold

Cell Adhesion Behavior, Fabrication and Surface-Modification of Chitosan Scaffolds

Fabrication, Surface Modification and Analysis of Biocompatibility of Biologic Chitosan Scaffold

Chitosan/gelatin Porous Scaffolds Containing Hyaluronic Acid and Heparan Sulfate for Neural Tissue Engineering

Transplantation of BDNF Gene Recombinant Mesenchymal Stem Cel Ls and Adhesive Peptide-modified Hydrogel Scaffold for Spinal Cord Repa Ir

The Biocompatibility of Multi-Source Stem Cells and Gelatin-Carboxymethyl Chitosan-Sodium Alginate Hybrid Biomaterials

Development of Collagen-chitosan Scaffold and Its Combination with Bone Marrow Stem Cells

Transplantation of BDNF Gene Recombinant Mesenchymal Stem Cells and Adhesive Peptide-modified Hydrogel Scaffold for Spinal Cord Repair

In Vitro Evaluation of the Cytocompatibility of an Acellular Rat Brain Matrix Scaffold with Neural Stem Cells

Production of Composite Scaffold Containing Silk Fibroin, Chitosan, and Gelatin for 3D Cell Culture and Bone Tissue Regeneration.

Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2.

PLA tissue-engineered scaffolds loaded with sustained-release active substance chitosan nanoparticles: Modeling BSA-bFGF as the active substance

Ectopic Osteogenesis and Scaffold Biodegradation of Tissue Engineering Bone Composed of Chitosan and Osteo-Induced Bone Marrow Mesenchymal Stem Cells in Vivo

In Situ-Forming Chitosan/nano-Hydroxyapatite/collagen Gel for the Delivery of Bone Marrow Mesenchymal Stem Cells